Quercetin inhibits rhinovirus replication in vitro and in vivo

Antiviral Research

Volumn 94, Issue 3, 2012, Pages 258-271

  Ganesan, Shyamala ^a   Faris, Andrea N ^a   Comstock, Adam T ^a   Wang, Qiong ^a   Nanua, Suparna ^a   Hershenson, Marc B ^a,b   Sajjan, Uma S ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Infection; Inflammation; Transcription; Translation

Indexed keywords

ALPHA INTERFERON; CAPSID PROTEIN; CXCL1 CHEMOKINE; CXCL2 CHEMOKINE; EARLY ENDOSOME ANTIGEN 1; INITIATION FACTOR 2ALPHA; INITIATION FACTOR 4G; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 8; LOW DENSITY LIPOPROTEIN RECEPTOR; MONOCYTE CHEMOTACTIC PROTEIN 1; PROTEIN KINASE B; QUERCETIN; TUMOR NECROSIS FACTOR ALPHA; VIRUS RNA;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG HALF LIFE; ENDOCYTOSIS; EPITHELIUM CELL; GENE AMPLIFICATION; GENETIC TRANSCRIPTION; IN VITRO STUDY; IN VIVO STUDY; INTERFERON PRODUCTION; LUNG FUNCTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RESPIRATORY TRACT ALLERGY; RHINOVIRUS; RNA TRANSLATION; SIGNAL TRANSDUCTION; VIRAL CLEARANCE; VIRUS GENOME; VIRUS LOAD; VIRUS REPLICATION;

ANIMALS; ANTIVIRAL AGENTS; CELL LINE; DISEASE MODELS, ANIMAL; EPITHELIAL CELLS; HUMANS; INTERFERONS; INTERLEUKIN-8; LUNG; MICE; MICE, INBRED C57BL; PICORNAVIRIDAE INFECTIONS; QUERCETIN; RHINOVIRUS; TREATMENT OUTCOME; VIRAL LOAD;

MIRIDAE; MUS; RHINOVIRUS;

EID: 84861226787     PISSN: 01663542     EISSN: 18729096     Source Type: Journal    
DOI: 10.1016/j.antiviral.2012.03.005     Document Type: Article

References (69)

1. Agullo G., Gamet-Payrastre L., Manenti S., Viala C., Remesy C., Chap H., Payrastre B. Relationship between flavonoid structure and inhibition of phosphatidylinositol 3-kinase: a comparison with tyrosine kinase and protein kinase C inhibition. Biochem. Pharmacol. 1997, 53:1649-1657.
2. Bentley J.K., Newcomb D.C., Goldsmith A.M., Jia Y., Sajjan U.S., Hershenson M.B. Rhinovirus activates interleukin-8 expression via a Src/p110beta phosphatidylinositol 3-kinase/Akt pathway in human airway epithelial cells. J. Virol. 2007, 81:1186-1194.
3. Boots A.W., Haenen G.R., Bast A. Health effects of quercetin: from antioxidant to nutraceutical. Eur. J. Pharmacol. 2008, 585:325-337.
4. Boots A.W., Li H., Schins R.P., Duffin R., Heemskerk J.W., Bast A., Haenen G.R. The quercetin paradox. Toxicol. Appl. Pharmacol. 2007, 222:89-96.
5. Castrillo J.L., Carrasco L. Action of 3-methylquercetin on poliovirus RNA replication. J. Virol. 1987, 61:3319-3321.
6. Chattoraj S.S., Ganesan S., Faris A., Comstock A., Lee W.M., Sajjan U.S. Pseudomonas aeruginosa suppresses interferon response to rhinovirus infection in cystic fibrosis, but not in normal bronchial epithelial cells. Infect. Immun. 2011, 79:4131-4145.
7. Chen L., Li J., Luo C., Liu H., Xu W., Chen G., Liew O.W., Zhu W., Puah C.M., Shen X., Jiang H. Binding interaction of quercetin-3-beta-galactoside and its synthetic derivatives with SARS-CoV 3CL(pro): structure-activity relationship studies reveal salient pharmacophore features. Bioorg. Med. Chem. 2006, 14:8295-8306.
8. Chiang L.C., Chiang W., Liu M.C., Lin C.C. In vitro antiviral activities of Caesalpinia pulcherrima and its related flavonoids. J. Antimicrob. Chemother. 2003, 52:194-198.
9. Conquer J.A., Maiani G., Azzini E., Raguzzini A., Holub B.J. Supplementation with quercetin markedly increases plasma quercetin concentration without effect on selected risk factors for heart disease in healthy subjects. J. Nutr. 1998, 128:593-597.
10. Davies S.P., Reddy H., Caivano M., Cohen P. Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem. J. 2000, 351:95-105.
11. Davis J.M., Murphy E.A., McClellan J.L., Carmichael M.D., Gangemi J.D. Quercetin reduces susceptibility to influenza infection following stressful exercise. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2008, 295:R505-R509.
12. De Meyer N., Haemers A., Mishra L., Pandey H.K., Pieters L.A., Vanden Berghe D.A., Vlietinck A.J. 4'-Hydroxy-3-methoxyflavones with potent antipicornavirus activity. J. Med. Chem. 1991, 34:736-746.
13. Foeger N., Schmid E.M., Skern T. Human rhinovirus 2 2Apro recognition of eukaryotic initiation factor 4GI. Involvement of an exosite. J. Biol. Chem. 2003, 278:33200-33207.
14. Gale M.J., Korth M.J., Tang N.M., Tan S.L., Hopkins D.A., Dever T.E., Polyak S.J., Gretch D.R., Katze M.G. Evidence that hepatitis C virus resistance to interferon is mediated through repression of the PKR protein kinase by the nonstructural 5A protein. Virology 1997, 230:217-227.
15. Ganesan S., Faris A.N., Comstock A.T., Chattoraj S.S., Chattoraj A., Burgess J.R., Curtis J.L., Martinez F.J., Zick S., Hershenson M.B., Sajjan U.S. Quercetin prevents progression of disease in elastase/LPS-exposed mice by negatively regulating MMP expression. Respir. Res. 2010, 11:131.
16. Glaser W., Skern T. Extremely efficient cleavage of eIF4G by picornaviral proteinases L and 2A in vitro. FEBS Lett. 2000, 480:151-155.
17. Gonzalez O., Fontanes V., Raychaudhuri S., Loo R., Loo J., Arumugaswami V., Sun R., Dasgupta A., French S.W. The heat shock protein inhibitor quercetin attenuates hepatitis C virus production. Hepatology 2009, 50:1756-1764.
18. Gradi A., Svitkin Y.V., Sommergruber W., Imataka H., Morino S., Skern T., Sonenberg N. Human rhinovirus 2A proteinase cleavage sites in eukaryotic initiation factors (eIF) 4GI and eIF4GII are different. J. Virol. 2003, 77:5026-5029.
19. Groskreutz D.J., Babor E.C., Monick M.M., Varga S.M., Hunninghake G.W. Respiratory syncytial virus limits alpha subunit of eukaryotic translation initiation factor 2 (eIF2alpha) phosphorylation to maintain translation and viral replication. J. Biol. Chem. 2010, 285:24023-24031.
20. Harwood M., Danielewska-Nikiel B., Borzelleca J.F., Flamm G.W., Williams G.M., Lines T.C. A critical review of the data related to the safety of quercetin and lack of evidence of in vivo toxicity, including lack of genotoxic/carcinogenic properties. Food Chem. Toxicol. 2007, 45:2179-2205.
21. Hellen C.U., Krausslich H.G., Wimmer E. Proteolytic processing of polyproteins in the replication of RNA viruses. Biochemistry 1989, 28:9881-9890.
22. Hollman P.C., de Vries J.H., van Leeuwen S.D., Mengelers M.J., Katan M.B. Absorption of dietary quercetin glycosides and quercetin in healthy ileostomy volunteers. Am. J. Clin. Nutr. 1995, 62:1276-1282.
23. Hsu N.Y., Ilnytska O., Belov G., Santiana M., Chen Y.H., Takvorian P.M., Pau C., van der Schaar H., Kaushik-Basu N., Balla T., Cameron C.E., Ehrenfeld E., van Kuppeveld F.J., Altan-Bonnet N. Viral reorganization of the secretory pathway generates distinct organelles for RNA replication. Cell 2010, 141:799-811.
24. Huang Y.T., Hwang J.J., Lee P.P., Ke F.C., Huang J.H., Huang C.J., Kandaswami C., Middleton E., Lee M.T. Effects of luteolin and quercetin, inhibitors of tyrosine kinase, on cell growth and metastasis-associated properties in A431 cells overexpressing epidermal growth factor receptor. Br. J. Pharmacol. 1999, 128:999-1010.
25. Hung M., Gibbs C.S., Tsiang M. Biochemical characterization of rhinovirus RNA-dependent RNA polymerase. Antiviral Res. 2002, 56:99-114.
26. Jacobs B.L., Langland J.O. When two strands are better than one: the mediators and modulators of the cellular responses to double-stranded RNA. Virology 1996, 219:339-349.
27. Jiang J.S., Shih C.M., Wang S.H., Chen T.T., Lin C.N., Ko W.C. Mechanisms of suppression of nitric oxide production by 3-O-methylquercetin in RAW 264.7 cells. J. Ethnopharmacol. 2006, 103:281-287.
28. Johnston S.L., Pattemore P.K., Sanderson G., Smith S., Lampe F., Josephs L., Symington P., O'Toole S., Myint S.H., Tyrrell D.A., et al. Community study of role of viral infections in exacerbations of asthma in 9-11 year old children. Br. Med. J. 1995, 310:1225-1229.
29. Johnston S.L., Tyrrell D.A.J. Rhinoviruses. Diagnostic Procedures for Viral, Rickettsial, and Chlamydial Infections 1997, 533-563. American Public Health Association, Washington DC. E.H. Lennette, N.J. Schmidt (Eds.).
30. Justino G.C., Santos M.R., Canario S., Borges C., Florencio M.H., Mira L. Plasma quercetin metabolites: structure-antioxidant activity relationships. Arch. Biochem. Biophys. 2004, 432:109-121.
31. Kaul T.N., Middleton E., Ogra P.L. Antiviral effect of flavonoids on human viruses. J. Med. Virol. 1985, 15:71-79.
32. Kim M.K., Park K.S., Yeo W.S., Choo H., Chong Y. In vitro solubility, stability and permeability of novel quercetin-amino acid conjugates. Bioorg. Med. Chem. 2009, 17:1164-1171.
33. Kim M.K., Park K.S., Lee C., Park H.R., Choo H., Chong Y. Enhanced stability and intracellular accumulation of quercetin by protection of the chemically or metabolically susceptible hydroxyl groups with a pivaloxymethyl (POM) promoiety. J. Med. Chem. 2010, 53:8597-8607.
34. Kim Y., Narayanan S., Chang K.O. Inhibition of influenza virus replication by plant-derived isoquercetin. Antiviral Res. 2010, 88:227-235.
35. Krenn B.M., Holzer B., Gaudernak E., Triendl A., van Kuppeveld F.J., Seipelt J. Inhibition of polyprotein processing and RNA replication of human rhinovirus by pyrrolidine dithiocarbamate involves metal ions. J. Virol. 2005, 79:13892-13899.
36. Lau C., Wang X., Song L., North M., Wiehler S., Proud D., Chow C.W. Syk associates with clathrin and mediates phosphatidylinositol 3-kinase activation during human rhinovirus internalization. J. Immunol. 2008, 180:870-880.
37. Li S., Min J.Y., Krug R.M., Sen G.C. Binding of the influenza A virus NS1 protein to PKR mediates the inhibition of its activation by either PACT or double-stranded RNA. Virology 2006, 349:13-21.
38. Makela M.J., Puhakka T., Ruuskanen O., Leinonen M., Saikku P., Kimpimaki M., Blomqvist S., Hyypia T., Arstila P. Viruses and bacteria in the etiology of the common cold. J. Clin. Microbiol. 1998, 36:539-542.
39. Mallia P., Message S.D., Gielen V., Contoli M., Gray K., Kebadze T., Aniscenko J., Laza-Stanca V., Edwards M.R., Slater L., Papi A., Stanciu L.A., Kon O.M., Johnson M., Johnston S.L. Experimental rhinovirus infection as a human model of chronic obstructive pulmonary disease exacerbation. Am. J. Respir. Crit. Care Med. 2011, 183:734-742.
40. Mallia P., Message S.D., Kebadze T., Parker H.L., Kon O.M., Johnston S.L. An experimental model of rhinovirus induced chronic obstructive pulmonary disease exacerbations: a pilot study. Respir. Res. 2006, 7:116.
41. Meredith J.M., Rohll J.B., Almond J.W., Evans D.J. Similar interactions of the poliovirus and rhinovirus 3D polymerases with the 3' untranslated region of rhinovirus 14. J. Virol. 1999, 73:9952-9958.
42. Message S.D., Laza-Stanca V., Mallia P., Parker H.L., Zhu J., Kebadze T., Contoli M., Sanderson G., Kon O.M., Papi A., Jeffery P.K., Stanciu L.A., Johnston S.L. Rhinovirus-induced lower respiratory illness is increased in asthma and related to virus load and Th1/2 cytokine and IL-10 production. Proc. Natl. Acad. Sci. USA 2008, 105:13562-13567.
43. Mosser A.G., Brockman-Schneider R., Amineva S., Burchell L., Sedgwick J.B., Busse W.W., Gern J.E. Similar frequency of rhinovirus-infectible cells in upper and lower airway epithelium. J. Infect. Dis. 2002, 185:734-743.
44. Murota K., Terao J. Antioxidative flavonoid quercetin: implication of its intestinal absorption and metabolism. Arch. Biochem. Biophys. 2003, 417:12-17.
45. Nagarkar D.R., Wang Q., Shim J., Zhao Y., Tsai W.C., Lukacs N.W., Sajjan U., Hershenson M.B. CXCR2 is required for neutrophilic airway inflammation and hyperresponsiveness in a mouse model of human rhinovirus infection. J. Immunol. 2009, 183:6698-6707.
46. Nanua S., Zick S.M., Andrade J.E., Sajjan U.S., Burgess J.R., Lukacs N.W., Hershenson M.B. Quercetin blocks airway epithelial cell chemokine expression. Am. J. Respir. Cell Mol. Biol. 2006, 35:602-610.
47. Newcomb D.C., Sajjan U., Nanua S., Jia Y., Goldsmith A.M., Bentley J.K., Hershenson M.B. Phosphatidylinositol 3-kinase is required for rhinovirus-induced airway epithelial cell interleukin-8 expression. J. Biol. Chem. 2005, 280:36952-36961.
48. Newcomb D.C., Sajjan U.S., Nagarkar D.R., Wang Q., Nanua S., Zhou Y., McHenry C.L., Hennrick K.T., Tsai W.C., Bentley J.K., Lukacs N.W., Johnston S.L., Hershenson M.B. Human rhinovirus 1B exposure induces phosphatidylinositol 3-kinase-dependent airway inflammation in mice. Am. J. Respir. Crit. Care Med. 2008, 177:1111-1121.
49. Neznanov N., Kondratova A., Chumakov K.M., Neznanova L., Kondratov R., Banerjee A.K., Gudkov A.V. Quercetinase pirin makes poliovirus replication resistant to flavonoid quercetin. DNA Cell Biol. 2008, 27:191-198.
50. Nieman D.C., Henson D.A., Gross S.J., Jenkins D.P., Davis J.M., Murphy E.A., Carmichael M.D., Dumke C.L., Utter A.C., McAnulty S.R., McAnulty L.S., Mayer E.P. Quercetin reduces illness but not immune perturbations after intensive exercise. Med. Sci. Sports Exerc. 2007, 39:1561-1569.
51. Nieman D.C., Williams A.S., Shanely R.A., Jin F., McAnulty S.R., Triplett N.T., Austin M.D., Henson D.A. Quercetin's influence on exercise performance and muscle mitochondrial biogenesis. Med. Sci. Sports Exerc. 2010, 42:338-345.
52. Peet G.W., Li J. IkappaB kinases alpha and beta show a random sequential kinetic mechanism and are inhibited by staurosporine and quercetin. J. Biol. Chem. 1999, 274:32655-32661.
53. Prajda N., Singhal R.L., Yeh Y.A., Olah E., Look K.Y., Weber G. Linkage of reduction in 1-phosphatidylinositol 4-kinase activity and inositol 1,4,5-trisphosphate concentration in human ovarian carcinoma cells treated with quercetin. Life Sci. 1995, 56:1587-1593.
54. Prchla E., Kuechler E., Blaas D., Fuchs R. Uncoating of human rhinovirus serotype 2 from late endosomes. J. Virol. 1994, 68:3713-3723.
55. Proud C.G. EIF2 and the control of cell physiology. Semin. Cell Dev. Biol. 2005, 16:3-12.
56. Qian X., Karpova T., Sheppard A.M., McNally J., Lowy D.R. E-cadherin-mediated adhesion inhibits ligand-dependent activation of diverse receptor tyrosine kinases. EMBO J. 2004, 23:1739-1748.
57. Rogerio A.P., Kanashiro A., Fontanari C., da Silva E.V., Lucisano-Valim Y.M., Soares E.G., Faccioli L.H. Anti-inflammatory activity of quercetin and isoquercitrin in experimental murine allergic asthma. Inflamm. Res. 2007, 56:402-408.
58. Sajjan U., Ganesan S., Comstock A.T., Shim J., Wang Q., Nagarkar D.R., Zhao Y., Goldsmith A.M., Sonstein J., Linn M.J., Curtis J.L., Hershenson M.B. Elastase- and LPS-exposed mice display altered responses to rhinovirus infection. Am. J. Physiol. 2009, 297:L931-944.
59. Seemungal T., Harper-Owen R., Bhowmik A., Moric I., Sanderson G., Message S., Maccallum P., Meade T.W., Jeffries D.J., Johnston S.L., Wedzicha J.A. Respiratory viruses, symptoms, and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2001, 164:1618-1623.
60. Seemungal T.A., Harper-Owen R., Bhowmik A., Jeffries D.J., Wedzicha J.A. Detection of rhinovirus in induced sputum at exacerbation of chronic obstructive pulmonary disease. Eur. Respir. J. 2000, 16:677-683.
61. Sreenivasulu K., Raghu P., Nair K.M. Polyphenol-rich beverages enhance zinc uptake and metallothionein expression in Caco-2 cells. J. Food Sci. 2010, 75:H123-128.
62. Tal M.C., Iwasaki A. Mitoxosome: a mitochondrial platform for cross-talk between cellular stress and antiviral signaling. Immunol. Rev. 2011, 243:215-234.
63. Tan S.L., Katze M.G. How hepatitis C virus counteracts the interferon response: the jury is still out on NS5A. Virology 2001, 284:1-12.
64. Terao J., Murota K., Kawai Y. Conjugated quercetin glucuronides as bioactive metabolites and precursors of aglycone in vivo. Food Funct. 2011, 2:11-17.
65. Vlahos C.J., Matter W.F., Hui K.Y., Brown R.F. A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002). J. Biol. Chem. 1994, 269:5241-5248.
66. Wang Q., Miller D.J., Bowman E.R., Nagarkar D.R., Schneider D., Zhao Y., Linn M.J., Goldsmith A.M., Bentley J.K., Sajjan U.S., Hershenson M.B. MDA5 and TLR3 initiate pro-inflammatory signaling pathways leading to rhinovirus-induced airways inflammation and hyperresponsiveness. PLoS Pathog. 2011, 7:e1002070.
67. Wang Q., Nagarkar D.R., Bowman E.R., Schneider D., Gosangi B., Lei J., Zhao Y., McHenry C.L., Burgens R.V., Miller D.J., Sajjan U., Hershenson M.B. Role of double-stranded RNA pattern recognition receptors in rhinovirus-induced airway epithelial cell responses. J. Immunol. 2009, 183:6989-6997.
68. Williams R.J., Spencer J.P., Rice-Evans C. Flavonoids: antioxidants or signalling molecules?. Free Radic. Biol. Med. 2004, 36:838-849.
69. Winther B. Rhinovirus infections in the upper airway. Proc. Am. Thor. Soc. 2011, 8:79-89.